Transcription of Q 7 Good Manufacturing Practice for Active …
{{id}} {{{paragraph}}}
European Medicines Agency 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 85 75 Fax (44-20) 75 23 70 40 E-mail: EMEA 2006 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged November 2000 CPMP/ICH/4106/00 ICH Topic Q 7 good Manufacturing Practice for Active Pharmaceutical Ingredients Step 5 NOTE FOR GUIDANCE ON good Manufacturing Practice FOR Active PHARMACEUTICAL INGREDIENTS (CPMP/ICH/4106/00) TRANSMISSION TO CPMP July 2000 RELEASE FOR CONSULTATION July 2000 DEADLINE FOR COMMENTS September 2000 SUBMISSION TO CPMP FOR INFORMATION November 2000 RELEASE FOR INFORMATION November 2000 Note: Date for coming into operation for this guideline will be released by the E
purposes of this Guide, the terms “current good manufacturing practices” and “good manufacturing practices” are equivalent. The Guide as a whole does not cover safety aspects for the personnel engaged in the manufacture, nor aspects of protection of the environment. These controls are inherent
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}